Exendin-4, but not dipeptidyl peptidase IV inhibition, increases small intestinal mass in GK rats (Q58448396)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17431213%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Exendin-4, but not dipeptidyl peptidase IV inhibition, increases small intestinal mass in GK rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17431213%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17431213%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Bolette Hartmann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17431213%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jens Juul Holst

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17431213%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Carolyn F. Deacon

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17431213%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

3

Cathrine Orskov

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17431213%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Lotte Simonsen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17431213%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Sofie Pilgaard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17431213%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

12 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17431213%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Gastrointestinal and Liver Physiology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17431213%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

293

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17431213%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17431213%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

G288-95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17431213%20AND%20SRC:MED&resulttype=core&format=json

Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Role of leptin in the regulation of glucagon-like peptide-1 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

GLP-2 stimulates intestinal growth in premature TPN-fed pigs by suppressing proteolysis and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Release of exendin-4 is controlled by mechanical action in Gila monsters, Heloderma suspectum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Therapeutic strategies based on glucagon-like peptide 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Ups and downs for neuropeptides in body weight homeostasis: pharmacological potential of cocaine amphetamine regulated transcript and pre-proglucagon-derived peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

International Union of Pharmacology. XXXV. The glucagon receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Glucagon-Like Peptides GLP-1 and GLP-2, Predicted Products of the Glucagon Gene, Are Secreted Separately from Pig Small Intestine but Not Pancreas*

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Twelve-week monotherapy with the DPP-4 inhibitor vildagliptin improves glycemic control in subjects with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Glucagon-like peptide 2 (GLP-2), an intestinotrophic mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Intestinal growth-promoting properties of glucagon-like peptide-2 in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Impaired intestinal proglucagon processing in mice lacking prohormone convertase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00453.2006

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00453.2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17431213%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference